PPA (Phenylpropanolamine)
The FDA (Food and Drug Administration)
announced on November 6, 2000 that they were taking steps
to remove PPA (phenylpropanolamine) from all drug
products. To begin this process they issued a public
health advisory concerning the risk of hemorrhagic stroke
(bleeding in the brain) associated with
phenylpropanolamine (PPA). PPA is used in many over the
counter (OTC) and prescription medications as a
decongestant in cough/cold preparations. There are also a
few OTC weight loss products that contain PPA.
PPA is one member of a broad class of
chemical entities known as ephedrine alkaloids. Ephedrine
is also a member of this class, but it should not be
confused with PPA. The plant material from Ma Huang (the
natural source for ephedrine) contains a mixture of
ephedrine alkaloids. Included in this mixture would be
some PPA, but the amount of PPA in Ma Huang is extremely
low. The preferred alkaloid in nature is ephedrine.
Although ephedrine and PPA are similar
in chemical structure, they are quite different in
pharmacologic activity. The pharmaceutical industry
synthesizes PPA which is then administered in the
cough/cold preparation in high doses (up to 75 mg per
dose). Natures Sunshine Products utilizes Ma Huang which
is measured in ephedrine alkaloids. Of these alkaloids,
ephedrine is by far the major constituent with PPA and
several other ephedrine alkaloids being very minor
components.
Natures Sunshine Products does not
utilize PPA in any of its products. Natures Sunshine
Products utilizes only the Ma Huang plant as its source of
ephedrine alkaloids, ephedrine being the major alkaloid in
the plant.
Clell M. Fowles
Manager R&D Health Sciences
Pharmacist
Natures Sunshine Products Research and Development
Jerry L. McLaughlin, Ph.D
Vice President Research and Development/Quality Assurance
Chief Scientific Officer (CSO)